malignancy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Participants aged = 18 years. 2) Patients with a histopathological or clinical diagnosis of advanced malignant tumors. 3) Individuals who can fully comprehend the content of this study, have the ability to adhere to the follow-up plan, sign the informed consent form, and voluntarily participate in this research.
Exclusion criteria
Exclusion criteria: 1) Age < 18 years. 2) Pathologically diagnosed as a benign tumor. 3) Tumor staging classified as early-stage. 4) Presence of cognitive impairment. 5) Patients who are unable to understand or comply with the study procedures and sign the informed consent form.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patient reported outcomes; | — |
Secondary
| Measure | Time frame |
|---|---|
| Core symptom cluster;time to functional recovery;overall survival time;Follow-up completion rate;Progression Free Survival;Overall Response Rate;time to change of treatment regimens;Adverse event rate; | — |
Countries
China
Contacts
Shaoxing Second Hospital